Biocellvia was created in September 2011 by Prof. Yvon Julé and his son Olivier. As early as 2011, they made the following observation: throughout the development cycle of a drug, scientists work from subjective data, in particular for the evaluation of the effectiveness of molecules, which has the direct consequence a high failure rate in the clinical phase.
In order to address this major problem, Biocellvia has developed tests using digital images of histological sections to better assess drug candidates specifically for each pathology. These tests provide scientists with very accurate, precise and reliable data, ideal for informed decision-making.
Building on Professor Yvon Julé’s academic career, renowned universities and researchers have quickly adopted this technology, which allows them to explain and discover new mechanisms, to better understand the evolution of a disease based on extremely robust data, which was not possible with the pathologist’s visual assessment.